| Literature DB >> 32256174 |
R Rajakrishnan1, A H Alfarhan1, A M Al-Ansari1, R Lekshmi2, R Sreelakshmi2, P B Benil3, Y-O Kim4, J-C Tack5, S W Na6, H-J Kim5.
Abstract
The phenomenal increase in the demand of herbal drugs, leads to over exploitation of medicinal plants which ultimately resulted in the scarcity and endangerment of many valuable plant species. On observing the difficulties in procuring genuine herbal drugs arose the concept of substitution which was documented in many classical Ayurvedic texts. The present study made a comparative evaluation of the gastroprotective potential of hydroalcoholic extracts of an original drug Aconitum heterophyllum (HAAH) and its substitute Cyperus rotundus (HACR) in the treatment of gastric ulcer under in vivo experimental conditions. The anti-ulcer property of the plant extracts was investigated against pylorus ligation induced ulcer in Wistar albino rats. The results confirmed that both A. heterophyllum and C. rotundus deliver comparable significant protection against gastric ulcer, indicated by a decrease in the free and total acidity, volume of gastric content, total proteins and increase in pH of gastric content, total carbohydrates and total carbohydrates to total proteins ratio. The observed anti-ulcer potential of both the drugs is attributed mainly to prevention of the generation of damaging free radical cascades and oxidant radical release.Entities:
Keywords: Acute toxicity; Cytotoxicity; Drug substitution; Histopathology; Lipid peroxidation
Year: 2019 PMID: 32256174 PMCID: PMC7105654 DOI: 10.1016/j.sjbs.2019.12.025
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 1319-562X Impact factor: 4.219
Cytotoxic effect of HAAH and HACR on MCF-7 cell line.
| Drugs | Concentration (µg) | IC50 | ||||||
| 0 | 20 | 50 | 100 | 200 | 500 | 1000 | ||
| % Viability | ||||||||
| HAAH | 90.59 ± 1.44 | 84.87 ± 1.43 | 77.63 ± 2.71 | 69.22 ± 0.89 | 61.69 ± 2.11 | 55.84 ± 3.79 | 45.99 ± 1.75 | 771.37 |
| HACR | 87.24 ± 1.63 | 69.68 ± 2.11 | 66.84 ± 1.39 | 63.28 ± 0.19 | 55.75 ± 3.53 | 50.38 ± 4.39 | 39.75 ± 0.38 | 603.16 |
Effect of Pantoprazole, HAAH and HACR on various gastric parameters.
| Groups | pH | Gastric juice volume (ml) | Free acidity (mEq/L) | Total acidity (mEq/L) | Total carbohydrates (µg/ml) | Total proteins (µg/ml) | CP Ratio |
|---|---|---|---|---|---|---|---|
| Ulcer Control | 1.5 ± 0.5 | 9.58 ± 1.01 | 26.33 ± 2.39 | 83.83 ± 6.74 | 534.22 ± 80.37 | 726.00 ± 99.66 | 0.73 ± 0.04 |
| Pantoprazole | 6.50 ± 0.42*** | 4.46 ± 0.33** | 12.67 ± 0.88* | 41.17 ± 3.98** | 958.82 ± 153.34** | 280.96 ± 43.06** | 3.40 ± 0.06** |
| HAAH 200 | 3.08 ± 0.27 | 5.56 ± 1.02 | 15.83 ± 1.74 | 47.00 ± 3.59* | 739.25 ± 72.85 | 248.13 ± 35.57** | 2.96 ± 0.05** |
| HAAH 400 | 4.83 ± 0.48** | 3.52 ± 0.22** | 11.17 ± 1.42** | 28.50 ± 2.46** | 1283.16 ± 219.75** | 309.98 ± 10.47** | 4.14 ± 0.09** |
| HACR 200 | 3.75 ± 0.30 | 6.35 ± 0.89 | 17.50 ± 1.73 | 52.66 ± 3.86* | 704.8 ± 96.75 | 270.75 ± 20.84** | 2.62 ± 0.03** |
| HACR 400 | 3.16 ± 0.44 | 4.98 ± 1.05* | 13.06 ± 1.42* | 43.17 ± 4.05** | 983.34 ± 119.75** | 273.07 ± 18.44** | 3.61 ± 0.08** |
Data: MEAN ± SEM, ***P < 0.001; **P < 0.01; *P < 0.05 in comparison to ulcer control group.
Effect of Pantoprazole, HAAH and HACR on antioxidant parameters.
| Groups | Catalase (µM of H2O2 consumed/min/mg protein) | Glutathione peroxidase (µM of GSH oxidized/min/mg protein) | Lipid peroxidation (µM of MDA formed/g wet tissue) |
|---|---|---|---|
| Ulcer Control | 18.95 ± 0.89 | 2.10 ± 0.22 | 9.91 ± 0.48 |
| Pantoprazole | 30.62 ± 0.79** | 4.76 ± 0.34** | 3.69 ± 0.23** |
| HAAH 200 mg/kg | 25.58 ± 2.38 | 2.92 ± 0.18 | 5.25 ± 0.19 |
| HAAH 400 mg/kg | 29.89 ± 1.13* | 4.37 ± 0.41** | 2.52 ± 0.16** |
| HACR 200 mg/kg | 21.71 ± 1.54 | 3.14 ± 0.29 | 6.00 ± 0.84 |
| HACR 400 mg/kg | 42.32 ± 1.46** | 3.79 ± 0.37* | 3.42 ± 0.69** |
Data: MEAN ± SEM, **P < 0.01; *P < 0.05 in comparison to ulcer control group.
Fig. 1Histopathological examinations of gastric mucosal tissue sections of rats (a) Ulcer control group (b) Pantoprazole treated (c) HAAH 200 mg/kg treated (d) HAAH 400 mg/kg treated (e) HACR 200 mg/kg treated (f) HACR 400 mg/kg treated.